Mizuho Securities USA LLC Raises Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Mizuho Securities USA LLC lifted its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 47.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,866 shares of the biotechnology company's stock after buying an additional 2,210 shares during the period. Mizuho Securities USA LLC's holdings in Axon Enterprise were worth $4,081,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Asset Dedication LLC increased its holdings in shares of Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock worth $106,000 after buying an additional 18 shares in the last quarter. Bleakley Financial Group LLC grew its position in shares of Axon Enterprise by 1.3% during the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock worth $908,000 after buying an additional 20 shares during the period. Venturi Wealth Management LLC raised its holdings in Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock worth $477,000 after purchasing an additional 21 shares during the period. Insigneo Advisory Services LLC grew its stake in Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock valued at $627,000 after acquiring an additional 22 shares during the period. Finally, Menard Financial Group LLC increased its stake in Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock worth $1,204,000 after purchasing an additional 24 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Axon Enterprise Stock Up 0.4 %

AXON traded up $2.35 during midday trading on Tuesday, reaching $574.87. The company's stock had a trading volume of 260,418 shares, compared to its average volume of 831,921. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock's 50-day moving average is $591.98 and its 200-day moving average is $545.11. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99. The firm has a market capitalization of $44.05 billion, a price-to-earnings ratio of 148.55, a PEG ratio of 5.17 and a beta of 1.12.

Analysts Set New Price Targets

AXON has been the subject of several analyst reports. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Robert W. Baird raised their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. Barclays restated a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. Finally, Needham & Company LLC reissued a "buy" rating and set a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $604.67.

Insider Buying and Selling at Axon Enterprise

In other news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 6.10% of the company's stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.